Location · Arkansas
Clinical trials recruiting in Arkansas
255 recruiting studies have at least one site in Arkansas; 48 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Arkansas.
255 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Little Rock, AR + 62 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
LB Pharmaceuticals Inc.
- Location
- Bentonville, AR + 12 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
LB Pharmaceuticals Inc.
- Location
- Bentonville, AR + 25 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Axsome Therapeutics, Inc.
- Location
- Little Rock, AR + 37 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Neurocrine Biosciences
- Location
- Bryant, AR + 38 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Edwards Lifesciences
- Location
- Little Rock, AR + 20 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 2
An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
Amgen
- Location
- Little Rock, AR + 3 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Little Rock, AR + 69 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
Arga Medtech SA
- Location
- Jonesboro, AR + 17 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Urotronic Inc.
- Location
- Little Rock, AR + 6 other US sites
- Eligibility basics
- Ages 50+ · Men only
- RecruitingPhase 1/Phase 2
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
Solid Biosciences Inc.
- Location
- Little Rock, AR + 11 other US sites
- Eligibility basics
- Ages 0 mo–17 · Men only
- RecruitingPhase 3
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
LEO Pharma
- Location
- North Little Rock, AR + 13 other US sites
- Eligibility basics
- Ages 6 mo–11
- RecruitingPhase 1
A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
GlaxoSmithKline
- Location
- Little Rock, AR + 11 other US sites
- Eligibility basics
- Ages 65–85
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Bristol-Myers Squibb
- Location
- Bentonville, AR + 19 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Neurocrine Biosciences
- Location
- Bryant, AR + 17 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- North Little Rock, AR + 112 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
Takeda
- Location
- Arkansas City, AR + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Pfizer
- Location
- Little Rock, AR + 13 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury
ONWARD Medical, Inc.
- Location
- Little Rock, AR + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Urovant Sciences GmbH
- Location
- Little Rock, AR + 6 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 2
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
AbbVie
- Location
- Little Rock, AR + 32 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Medical Devices
- Location
- Little Rock, AR + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Neurona Therapeutics
- Location
- Little Rock, AR + 34 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Nkarta, Inc.
- Location
- Little Rock, AR + 15 other US sites
- Eligibility basics
- Ages 18–75